IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
MIRN News
Archived Headlines
- Microcap IPOs on tap in coming weeks; several billion-dollar IPOs could follow 09/18/15
- Micro cancer fighter: Mirna Therapeutics sets terms for $65 million IPO 09/18/15
- US IPO Weekly Recap: Volatility rules a week with no IPOs and 6 new filings 08/28/15
- The micro cancer fighter: Mirna Therapeutics files for a $81 million IPO 08/24/15
US IPO Weekly Recap: Only five deals get done after massive valuation cuts
Home, home below the range: all five deals this week priced below the range. There were eleven companies on the IPO calendar this week, but only five were able to price, and each of those priced at least 19% below their...read more
Mirna Therapeutics prices IPO at $7, half the original midpoint
Mirna Therapeutics, which is developing microRNA replacement therapies for liver cancer, raised $44 million by offering 6.3 million shares at $7. Mirna Therapeutics plans to list on the Nasdaq under the symbol MIRN. Mirna Therapeutics initially filed confidentially on 3/12/2014. Citi and Leerink Partners acted as lead managers on the deal....read more
Mirna Therapeutics decreases proposed IPO deal size
Mirna Therapeutics, which is developing microRNA replacement therapies for liver cancer, lowered the proposed deal size for its upcoming IPO on Wednesday. The Austin, TX-based company now plans to raise $44 million by offering 6 million shares at a price of $7. The company had previously filed to offer 5 million shares at a range of $13 to $15. Mirna Therapeutics, which was...read more
Week ahead: 11 IPOs set to price during the week of September 28
The last week of September has 11 IPOs on the calendar – more IPOs than all of August 2015. Out of 134 offerings so far in 2015, 61 have been health care companies. Next week, 7 out of the 11 IPOs on the calendar are health care. A large foodservice distributor and three...read more